Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shu‐Oi Chow
Observed name:
Shu-Oi Chow
Institutions:
Australian Cancer Research Foundation,
UNSW Sydney
Observed institutions:
The University of Sydney,
Australian Cancer Research Foundation,
Royal North Shore Hospital,
UNSW Sydney,
Children's Cancer Institute Australia,
Anzac Research Institute
show all 6
ORCID:
0000-0003-4246-4527
Observed ORCID:
0000-0003-4246-4527
OpenAlex ID:
A5023588439
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
·
Cancer Research
·
56
PDF
Activated Protein C Enhances Human Keratinocyte Barrier Integrity via Sequential Activation of Epidermal Growth Factor Receptor and Tie2
2010
·
Meilang Xue
, Shu-Oi Chow
, et al.
·
Journal of Biological Chemistry
·
53
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
2020
·
Alvin Kamili
, Andrew J. Gifford
, et al.
·
British Journal of Cancer
·
52
PDF
Direct Crosstalk Between Cancer and Osteoblast Lineage Cells Fuels Metastatic Growth in Bone via Auto-Amplification of IL-6 and RANKL Signaling Pathways
2014
·
Yu Zheng
, Shu-Oi Chow
, et al.
·
Journal of Bone and Mineral Research
·
48
PDF
In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
2021
·
Loretta M S Lau
, Chelsea Mayoh
, et al.
·
EMBO Molecular Medicine
·
45
PDF
Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone
2014
·
Yu Zheng
, Dennis Basel
, et al.
·
Clinical & Experimental Metastasis
·
45
Endogenous protein C is essential for the functional integrity of human endothelial cells
2010
·
Meilang Xue
, Nikita Minhas
, et al.
·
Cellular and Molecular Life Sciences
·
19
The important role of routine cytopathology in pediatric precision oncology
2021
·
Jinhan Xie
, Amit Kumar
, et al.
·
Cancer Cytopathology
·
8
PDF
Supplementary Tables S1-S7 from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
Supplementary Figures from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
Supplementary Materials and Methods from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
PDF
Supplementary Figures and Figure Legends from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
Supplementary Figures from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
Data from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
Supplementary Figures from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
Supplementary Figures from High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
2023
·
Chelsea Mayoh
, Jie Mao
, et al.
PDF
Show more works
View as search
Works count:
16
Citation count:
326
H-index:
8
I10-index:
7
Year
Topic
Type
